Agile Therapeutics Equity Warrants AGXRW

Healthcare

Agile Therapeutics, Inc. is a women's healthcare company, which is engaged in fulfilling the unmet health needs of women. Its product and product candidates are designed to provide women with contraceptive options that offer freedom from taking a daily pill, without committing to a longer-acting method. Its initial product, Twirla, (levonorgestrel and ethinyl estradiol), a transdermal system, is a non-daily prescription contraceptive. Twirla is based on its proprietary transdermal patch technology, called Skinfusion, which is designed to allow drug delivery through the skin. Twirla (levonorgestrel and ethinyl estradiol) transdermal system is a once-weekly combined hormonal contraceptive (CHC) patch that contains the active ingredients levonorgestrel (LNG), a type of progestin, and ethinyl estradiol (EE), a type of estrogen. Its potential product pipeline consists of two types of product candidates: a progestin-only (P-only) contraceptive patch and potential Twirla line extensions.

GREY:AGXRW - Post by User

Agile Therapeutics Equity Warrants

<< Previous

Bullboard Posts

Next >>

Post by Iseneschalon Jun 27, 2023 11:37am

86 Views

Post# 35516393

AGRX..... What can I say that you don't.....

already know.

AGRX is at it's all-time low......and thats after all the good news and the total maniped share price during After Hours trading on 06/14/23...which was total BS

I can only say that " The Powers To Be" always will get their way and you will all get left holding a huge bag.

The rules a not in your favor

<< Previous

Bullboard Posts

Next >>

Advancing flagship Ishkõday Gold Project in Ontario